GlaxoSmith to cut number of brands to 20 in India, says report
Updated : August 20, 2018 11:15 AM IST
The UK-based drugmaker which has patented brands such as Calpol, Augmentin, Zinetac among others said it is planning on bringing more intellectual property products to India, especially in the respiratory and anti-infective space.
The top 10 brands of the company contributes almost 52.1 percent of GSK India’s sale.
In the past one year, the company has reduced the number of brands from 130 to 70, the report said.
Have you signed up for Primo, our daily newsletter?It has all the stories and data on the market, business, economy and tech that you need to know.
THANK YOU! You made our day. See you every morningYOUR EMAIL IS ON ITS WAY. Check your inbox for future updates.
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more